USV Launches Roseday CV at a Patient-Centric Price for Indian Cardiac Patients
Written By : Dr. Nandita Mohan
Published On 2023-08-24 06:34 GMT | Update On 2024-08-17 06:22 GMT
Advertisement
The recent AHA/ACC 2023 Guidelines for Chronic Coronary Disease recommend considering medication costs to prevent cost-related non-adherence.
Addressing this issue, USV Pvt. Ltd, a leading drug manufacturer in the diabetes and cardiology segments, has launched Roseday CV, which contains Rosuvastatin and Clopidogrel and is available in two SKUs: Roseday CV 10 at just 8.3 rupees per capsule, and Roseday CV 20 at 8.74 rupees per capsule.
It is widely available across India.
Disclaimer: This post has been published under MD Brand Connect Initiative and is sponsored by USV Private Limited.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.